AWM
BNGO icon

AE Wealth Management’s Bionano Genomics BNGO Stock Holding History

AE Wealth Management’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-23
Closed -$8.28K – 1959
2023
Q2 		$8.28K Sell
23
-21
-48% -$9.48K ﹤0.01% 1880
2023
Q1 		$29.5K Buy
44
+3
+7% +$2.67K ﹤0.01% 1836
2022
Q4 		$35.9K Buy
41
+4
+11% +$5.03K ﹤0.01% 1762
2022
Q3 		$41K Sell
37
-3
-8% -$3.96K ﹤0.01% 1696
2022
Q2 		$33K Sell
40
-1
-2% -$1.03K ﹤0.01% 1689
2022
Q1 		$63K Sell
41
-2
-5% -$2.7K ﹤0.01% 1628
2021
Q4 		$76K Sell
43
-13
-23% -$34.8K ﹤0.01% 1650
2021
Q3 		$186K Sell
56
-7
-11% -$24.5K ﹤0.01% 1532
2021
Q2 		$279K Buy
63
+25
+66% +$98.7K ﹤0.01% 1368
2021
Q1 		$184K Buy
+38
New +$214K ﹤0.01% 1412

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

AE Wealth Management's BNGO Position: Q3 2023 in Review

AE Wealth Management sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 23 shares — an estimated $8.28K sold.

AE Wealth Management first reported a position in BNGO in Q1 2021 and held it in 10 quarters. The position peaked at $279K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • AE Wealth Management reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • AE Wealth Management sold 23 Bionano Genomics shares in Q3 2023, an estimated $8.28K.
  • AE Wealth Management first reported a position in Bionano Genomics in Q1 2021 and held it in 10 quarters.
  • AE Wealth Management's Bionano Genomics position peaked at $279K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on AE Wealth Management's 13F filing for Q3 2023, filed 11 Oct 2023.